Kim Sablich, EVP & GM, North America at Jazz Pharmaceuticals plc (JAZZ), sold 5,496 shares at $135.01 ($742K) on 2021-11-11, disclosed to the SEC on 2021-11-15.
Open-market sale of $742k JAZZ by EVP & GM, North America. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $135.01 | 2,748 | $371K | 50.0% |
| 2 | $135.01 | 2,748 | $371K | 50.0% |
| Total | $135.01 avg | 5,496 | $742K | 100% |
| Filing → |
| MYOV | SELL | 2020-03-19 | $6K | — | Filing → |
| MYOV | SELL | 2020-01-16 | $136K | — | Filing → |
| MYOV | SELL | 2019-12-19 | $42K | — | Filing → |